Fredun Pharmaceuticals Limited (BOM:539730)
India · Delayed Price · Currency is INR 1,477.05
+25.45 (1.75%)
At close: Oct 16, 2026
Fredun Pharmaceuticals Market Cap
Fredun Pharmaceuticals has a market cap or net worth of 24.43 billion as of October 16, 2026. It is the 19,370th most valuable company in the world and the 1,168th biggest in India. Its market cap has increased by 254.23% in one year.
Market Cap
24.43B
Enterprise Value
26.20B
Revenue
7.44B
Global Rank
Country Rank
#1,168 India
PE Ratio
62.91
ChartMarket Cap Chart
Since March 28, 2016, Fredun Pharmaceuticals's market cap has increased from 29.40M to 24.43B, an increase of 82,972.81%. That is a compound annual growth rate of 89.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 24.43B | 227.79% |
| Dec 31, 2025 | 7.45B | 115.10% |
| Dec 31, 2024 | 3.46B | -15.14% |
| Dec 29, 2023 | 4.08B | -20.69% |
| Dec 30, 2022 | 5.15B | 37.31% |
| Dec 31, 2021 | 3.75B | 116.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 41.74B |
| Unichem Laboratories | 36.60B |
| Kwality Pharmaceuticals | 35.20B |
| Shukra Pharmaceuticals | 29.45B |
| Hikal | 26.95B |
| Venus Remedies | 21.22B |
| Syncom Formulations (India) | 21.12B |
| Amrutanjan Health Care | 14.54B |